Medicrea earns world's 1st FDA approval for patient-specific cages: 5 things to know

Mackenzie Garrity -   Print  |

Medicrea received FDA clearance for its patient-specific spinal cages using its UNiD technology.

Here are five things to know:

1. This is the first time a patient-specific spinal cage won FDA approval. Medicrea designed the 3D printed titanium devices using its IB3D predictive analytics model.

2. By using its UNiD IB3D, Medicrea eliminated the implant-selection stage. This helps reduce operating time while also providing the patient with an adaptable implant.

3. The cages are designed through X-rays and MRIs prior to surgery. Since first developing patient-specific implants, Medicrea has completed more than 2,400 surgeries.

4. Medicrea's cages build off its current patient-specific rods. The UNiD Rod earned FDA clearance in November 2014. It was the first patient-specific spinal implant to receive FDA approval.

5. Medicrea has also expanded its UNiD Adaptive Spine Intelligence platform with the new cages into its present UNiD Hub, an outcome-centered database used for surgical planning.

More articles on devices and implants:
Looking to enter the spine market? See the Xoran, Fiagon partnership
Global spine surgery products market to exceed $3.15B by 2022: 3 observations
Medtronic, Aurora Spine & more: 4 device company notes

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers